Sign in

CIK 0001858848 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Tenaya Therapeutics, Inc.

Sign in to watch
Ticker
TNYA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813789973
Phone
415-865-2066
Business address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
  1. 3 Insider Initial Statement of Ownership
  2. 8-K Event Executive or director change
  3. 4 Insider Changes in Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Executive or director change
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. SC 13G Stake Amended Statement of Ownership
  11. SC 13G Stake Amended Statement of Ownership
  12. SC 13G Stake Amended Statement of Ownership
  13. SC 13D Stake Beneficial Ownership Report
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
  20. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit

Page 16 of 18 · 353 filings